Navigation Links
Michael S. Watson, Ph.D., receives Am College of Medical Genetics-ACMG Foundation Presidents' Award
Date:4/4/2011

The ACMG and ACMG Foundation Presidents' Award has been newly established to thank and honor the valuable contributions made by a member of the American College of Medical Genetics. In a surprise announcement, Michael S. Watson, PhD, FACMG was named the first recipient of this new honor during the Presidential Plenary session at the 2011 ACMG Clinical Genetics Meeting in Vancouver, British Columbia in March.

"Despite the surprise, I am honored to have been the first recipient of this award. As with any award, thanks have to go to those who have allowed success to be realized including the many Boards of Directors and Committees of ACMG with which I have worked, the marvelous staff of the ACMG and ACMGF and the members of ACMG who work daily to deliver genetic services to patients," said Dr. Watson.

Dr. Watson received his B.S from American University in Washington, D.C. and his M.S. in Medical Genetics and Ph.D. in Physiology and Biophysics from the University of Alabama at Birmingham. He completed his postdoctoral fellowship in the Medical Genetics Training Program at Yale University School of Medicine. He has been Executive Director of the American College of Medical Genetics for the past 10 years and is an Adjunct Professor of Pediatrics at Washington University in St. Louis where he was Director of Clinical and Molecular Cytogenetics from 1986 2000. He is certified by the American Board of Medical Genetics in Clinical Cytogenetics and PhD Medical Genetics.

Dr. Watson has a long-standing interest in the translation of genetic information into health care use. He was a founder of the American College of Medical Genetics for which he has served as Vice President for Laboratory Affairs and has chaired its Test and Technology Transfer Committee, Economics Committee, Laboratory Practices Committee and Intellectual Property Committee. He co-chaired the NIH-ELSI/HHS Task Force on Genetics Testing from 1995 1997. Most recently, he was the project director for a MCHB/HRSA funded project to bring uniformity to newborn screening in the United States. He is currently the Director of the Health Resources and Services Administration (HRSA) funded National Coordinating Center for Regional Genetics and Newborn Screening for the Collaboratives and the Eunice Kennedy Shriver National Institute of Child Health and Human Development's Newborn Screening Translational Research Network (NBSTRN) Coordinating Center.

Dr. Watson has been the author of more than 100 peer-reviewed publications and book chapters.

"Mike Watson has been, without question, the most powerful force behind the success of the American College in Medical Genetics in establishing itself as the "go-to" authority on integration of genetics into medical practice," said ACMG's immediate past-president Bruce R. Korf, MD, PhD, FACMG. "There is no one in our community more deserving of our gratitude and recognition."

Dr. R. Rodney Howell, FACMG, president of the ACMG Foundation added, "Mike, as the first Executive Director of the American College of Medical Genetics, has been responsible for the dramatic expansion of the ACMG staff and the remarkable involvement of the organization in so many areas of genetics in the practice of medicine. With his outstanding leadership during this expansion, ACMG in the past ten years has demonstrated its critical role in the translation of genetic discoveries into the practice of medical genetics."


'/>"/>

Contact: Kathy Beal, MBA
kbeal@acmg.net
301-238-4582
American College of Medical Genetics
Source:Eurekalert

Related biology news :

1. 2011 HFSP Nakasone Award for Michael Elowitz of Caltech
2. Michael Graetzel wins the Millennium Technology Prize
3. Adult Star Katie Michaels Attending NHL Game 7 Red Wings vs. Coyotes
4. Michael Betenbaugh wins 2010 Cell Culture Engineering award
5. American Society for Microbiology honors J. Michael Miller
6. Pacific Biometrics, Inc. Announces the Appointment of Michael Murphy, PhD as Chief Operating Officer
7. Annual Michael & Susan Dell lectureship in child health
8. Autism Speaks chief science officer Geraldine Dawson, Ph.D., named Rock Star of Science
9. Marwan Khaled Tayeh, Ph.D., is awarded the 2010 Richard King Trainee Award
10. AACR applauds nomination of Francis S. Collins, M.D., Ph.D., to be the new NIH director
11. Sihoun Hahn, M.D., Ph.D., FACMG is the 2009-2010 Luminex/ACMGF Award recipient
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... CENTRE, N.Y. , March 27, 2017 /PRNewswire-USNewswire/ ... Healthcare Information and Management Systems Society (HIMSS) Analytics ... Outpatient EMR Adoption Model sm . In addition, ... 12% of U.S. hospitals using an electronic medical ... CHS for its high level of EMR usage ...
(Date:3/23/2017)... 23, 2017 Research and Markets has announced ... & Trends - Industry Forecast to 2025" report to their ... The ... CAGR of around 8.8% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/20/2017)... , March 20, 2017 At this year,s ... -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand ... is this year,s CeBIT partner country. At the largest German biometrics ... in use: fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics ... ...
Breaking Biology News(10 mins):
(Date:5/18/2017)... ... 2017 , ... Many complicated neurological disorders appear to have ... while men are at greater risk for Parkinson’s disease. Understanding some of the ... of a research program at Worcester Polytechnic Institute (WPI) funded by a new ...
(Date:5/16/2017)... , ... May 16, 2017 , ... ... and cancer diagnostics, has released its ClearID Lung Cancer blood test. Leveraging a ... cancer, this new test is designed to quickly and accurately identify tumor-related genetic ...
(Date:5/15/2017)... ... May 15, 2017 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today announced that it has signed an agreement ... support preclinical and clinical development of TA-46, a novel protein addressing achondroplasia, which ...
(Date:5/12/2017)... , May 12, 2017  Eli Lilly and Company ... galcanezumab, an investigational treatment for the prevention of ... in three Phase 3 studies (EVOLVE-1, EVOLVE-2 and ... of monthly migraine headache days compared to placebo ... robust results from these three studies bring us ...
Breaking Biology Technology: